BINHAI INV (02886) repurchased 130,000 shares for HK$153,300 on November 3.
BINHAI INV (02886) announced that on November 3, 2026, the company repurchased 130,000 shares for HK$153,300, at a repurchase price of HK$1.175 to HK$1.19 per share.
BINHAI INV (02886) announced that on November 3, 2026, the company repurchased 130,000 shares for HK$153,300, at a repurchase price of HK$1.175 to HK$1.19 per share.
Related Articles
.png)
SCIENTECH (02291) repurchased 35,000 shares on November 3 for approximately HK$488,600.
MEDLIVE (02192) repurchased 98,500 shares for HK$613,000 on November 3.
ChemPartner PharmaTech (300149.SZ) subsidiary plans to invest RMB10 million in Wuhan Bainuo Jiatai Venture Capital Partnership
SCIENTECH (02291) repurchased 35,000 shares on November 3 for approximately HK$488,600.
MEDLIVE (02192) repurchased 98,500 shares for HK$613,000 on November 3.
ChemPartner PharmaTech (300149.SZ) subsidiary plans to invest RMB10 million in Wuhan Bainuo Jiatai Venture Capital Partnership
